Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 146, Issue 1, 2009, Pages 44-53

  Morabito, Fortunato ^a,b   Cutrona, Giovanna ^c   Gentile, Massimo ^b   Matis, Serena ^c   Todoerti, Katia ^d   Colombo, Monica ^c   Sonaglio, Claudia ^c   Fabris, Sonia ^d   Reverberi, Daniele ^c   Megna, Mauro ^c   Spriano, Mauro ^c   Lucia, Eugenio ^b   Rossi, Edoardo ^c   Callea, Vincenzo ^e   Mazzone, Carla ^b   Festini, Gianluca ^f   Zupo, Simonetta ^c   Molica, Stefano ^g   Neri, Antonino ^d   Ferrarini, Manlio ^c,h  

^a Azienda Ospedaliera di Cosenza   (Italy)

^b Azienda Ospedaliera   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^f MAGGIORE HOSPITAL   (Italy)

^g PUGLIESE CIACCIO HOSPITAL   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

Author keywords

CD38; Chronic lymphocytic leukaemia; Gene expression profiling; IGHV mutational status; ZAP 70

Indexed keywords

CD38 ANTIGEN; PROTEIN KINASE ZAP 70; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

AGED; ANTIGENS, CD38; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GENETIC MARKERS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 66949121753     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07703.x     Document Type: Article

References (46)

1. Abruzzo, L.V., Barron, L.L., Anderson, K., Newman, R.J., Wierda, W.G., O'Brien, S., Ferrajoli, A., Luthra, M., Talwalkar, S., Luthra, R., Jones, D., Keating, M.J. Coombes, K.R. (2007) Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology. The Journal of Molecular Diagnostics, 9, 546 555. (Pubitemid 47434122)
2. Agnelli, L., Bicciato, S., Mattioli, M., Fabris, S., Intini, D., Verdelli, D., Baldini, L., Morabito, F., Callea, V., Lombardi, L. Neri, A. (2005) Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. Journal of Clinical Oncology, 23, 7296 7306. (Pubitemid 46202343)
3. Altman, D.G. (1991). Practical Statistics for Medical Research (ed. by Chapman and Hall London, New England.
4. Bomben, R., Dal Bo, M., Capello, D., Benedetti, D., Marconi, D., Zucchetto, A., Forconi, F., Maffei, R., Ghia, E.M., Laurenti, L., Bulian, P., Del Principe, M.I., Palermo, G., Thorselius, M., Degan, M., Campanini, R., Guarini, A., Del Poeta, G., Rosenquist, R., Efremov, D.G., Marasca, R., Foa, R., Gaidano, G. Gattei, V. (2007) Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. Blood, 109, 2989 2998. (Pubitemid 46482099)
5. Chaar, B.T., Schergen, A.K. Grosso, L.E. (2008) Discordance of ZAP-70 in patients with chronic lymphocytic leukemia. International Journal of Laboratory Hematology, 30, 36 40.
6. Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. Rai, K.R. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 4990 4997. (Pubitemid 26189840)
7. Chiorazzi, N., Rai, K.R. Ferrarini, M. (2005) Chronic lymphocytic leukemia. New England Journal of Medicine, 352, 804 815.
8. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marce, S., Lopez-Guillermo, A., Campo, E. Montserrat, E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. New England Journal of Medicine, 348, 1764 1775. (Pubitemid 36514707)
9. Cutrona, G., Colombo, M., Matis, S., Fabbi, M., Spriano, M., Callea, V., Vigna, E., Gentile, M., Zupo, S., Chiorazzi, N., Morabito, F. Ferrarini, M. (2008) Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells. Haematologica, 93, 413 422.
10. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840 1847. (Pubitemid 29430399)
11. Del Principe, M.I., Del Poeta, G., Buccisano, F., Maurillo, L., Venditti, A., Zucchetto, A., Marini, R., Niscola, P., Consalvo, M.A., Mazzone, C., Ottaviani, L., Panetta, P., Bruno, A., Bomben, R., Suppo, G., Degan, M., Gattei, V., de Fabritiis, P., Cantonetti, M., Lo Coco, F., Del Principe, D. Amadori, S. (2006) Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood, 108, 853 861. (Pubitemid 44154617)
12. Fabris, S., Mosca, L., Todoerti, K., Cutrona, G., Lionetti, M., Intini, D., Matis, S., Colombo, M., Agnelli, L., Gentile, M., Spriano, M., Callea, V., Festini, G., Molica, S., Lambertenghi Deliliers, G., Morabito, F., Ferrarini, M. Neri, A. (2008) Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia. Genes, Chromosomes and Cancer, 47, 781 793.
13. Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A., Allen, S.L., Schulman, P., Vinciguerra, V.P., Rai, K., Rassenti, L.Z., Kipps, T.J., Dighiero, G., Schroeder, H.W. Jr., Ferrarini, M. Chiorazzi, N. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. Journal of Clinical Investigation, 102, 1515 1525. (Pubitemid 28492218)
14. Gachard, N., Salviat, A., Boutet, C., Arnoulet, C., Durrieu, F., Lenormand, B., Lepretre, S., Olschwang, S., Jardin, F., Lafage-Pochitaloff, M., Penther, D., Sainty, D., Reminieras, L., Feuillard, J. Bene, M.C. (2008) Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method. Haematologica, 93, 215 223.
15. Ghia, P., Stamatopoulos, K., Belessi, C., Moreno, C., Stella, S., Guida, G., Michel, A., Crespo, M., Laoutaris, N., Montserrat, E., Anagnostopoulos, A., Dighiero, G., Fassas, A., Caligaris-Cappio, F. Davi, F. (2005) Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood, 105, 1678 1685. (Pubitemid 40223690)
16. Hallek, M., Cheson, B.D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Dohner, H., Hillmen, P., Keating, M.J., Montserrat, E., Rai, K.R. Kipps, T.J. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood, 111, 5446 5456.
17. Hamblin, T.J. (2007) ZAP-70 levels do change in CLL but not very often. Leukaemia and Lymphoma, 48, 1059 1060. (Pubitemid 47009192)
18. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848 1854. (Pubitemid 29430400)
19. Hamblin, T.J., Orchard, J.A., Ibbotson, R.E., Davis, Z., Thomas, P.W., Stevenson, F.K. Oscier, D.G. (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood, 99, 1023 1029. (Pubitemid 34525567)
20. Heintel, D., Kienle, D., Shehata, M., Krober, A., Kroemer, E., Schwarzinger, I., Mitteregger, D., Le, T., Gleiss, A., Mannhalter, C., Chott, A., Schwarzmeier, J., Fonatsch, C., Gaiger, A., Dohner, H., Stilgenbauer, S. Jager, U. (2005) High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia, 19, 1216 1223. (Pubitemid 40946007)
21. Hus, I., Podhorecka, M., Bojarska-Junak, A., Rolinski, J., Schmitt, M., Sieklucka, M., Wasik-Szczepanek, E. Dmoszynska, A. (2006) The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia. Annals of Oncology, 17, 683 690.
22. Huttmann, A., Klein-Hitpass, L., Thomale, J., Deenen, R., Carpinteiro, A., Nuckel, H., Ebeling, P., Fuhrer, A., Edelmann, J., Sellmann, L., Duhrsen, U. Durig, J. (2006) Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia, 20, 1774 1782. (Pubitemid 44574989)
23. Ibrahim, S., Keating, M., Do, K.A., O'Brien, S., Huh, Y.O., Jilani, I., Lerner, S., Kantarjian, H.M. Albitar, M. (2001) CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood, 98, 181 186.
24. Kay, N.E., O'Brien, S.M., Pettitt, A.R. Stilgenbauer, S. (2007) The role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia. Leukemia, 21, 1885 1891. (Pubitemid 47299960)
25. Keating, M.J., Chiorazzi, N., Messmer, B., Damle, R.N., Allen, S.L., Rai, K.R., Ferrarini, M. Kipps, T.J. (2003) Biology and treatment of chronic lymphocytic leukemia. Hematology. American Society of Hematology. Education Program, 1, 153 175.
26. Kim, S.Z., Chow, K.U., Kukoc-Zivojnov, N., Boehrer, S., Brieger, A., Steimle-Grauer, S.A., Harder, L., Hoelzer, D., Mitrou, P.S. Weidmann, E. (2004) Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status. Leukaemia and Lymphoma, 45, 2037 2045. (Pubitemid 39232852)
27. Le Garff-Tavernier, M., Ticchioni, M., Brissard, M., Salmon, C., Raynaud, S., Davi, F., Bernard, A., Merle-Beral, H., Ajchenbaum-Cymbalista, F. Letestu, R. (2007) National standardization of ZAP-70 determination by flow cytometry: the French experience. Cytometry. Part B, Clinical Cytometry, 72, 103 108. (Pubitemid 46365539)
28. Leupin, N., Cenni, B., Novak, U., Hugli, B., Graber, H.U., Tobler, A. Fey, M.F. (2003) Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL). British Journal of Haematology, 121, 97 100. (Pubitemid 36461273)
29. Li, F.J., Ding, S., Pan, J., Shakhmatov, M.A., Kashentseva, E., Wu, J., Li, Y., Soong, S.J., Chiorazzi, N. Davis, R.S. (2008) FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood, 112, 179 187.
30. Matrai, Z., Lin, K., Dennis, M., Sherrington, P., Zuzel, M., Pettitt, A.R. Cawley, J.C. (2001) CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. Blood, 97, 1902 1903. (Pubitemid 32217269)
31. Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia Marco, J., Houlihan, A., Que, T.H. Catovsky, D. (1994) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia, 8, 1640 1645. (Pubitemid 24323778)
32. Murray, F., Darzentas, N., Hadzidimitriou, A., Tobin, G., Boudjogra, M., Scielzo, C., Laoutaris, N., Karlsson, K., Baran-Marzsak, F., Tsaftaris, A., Moreno, C., Anagnostopoulos, A., Caligaris-Cappio, F., Vaur, D., Ouzounis, C., Belessi, C., Ghia, P., Davi, F., Rosenquist, R. Stamatopoulos, K. (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood, 111, 1524 1533. (Pubitemid 351213442)
33. O' Brien, S. Keating, M.J. (2005) Chronic lymphoid leukemias. In : Cancer Principle & Practise of Oncology (ed. by T. De Vita, J.S. Hellman S.A. Rosenberg Vol. 2, pp. 2133 2142. Lippincott Williams & Wilkins, Philadelphia.
34. Oppezzo, P., Vasconcelos, Y., Settegrana, C., Jeannel, D., Vuillier, F., Legarff-Tavernier, M., Kimura, E.Y., Bechet, S., Dumas, G., Brissard, M., Merle-Beral, H., Yamamoto, M., Dighiero, G. Davi, F. (2005) The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood, 106, 650 657. (Pubitemid 40981263)
35. Orchard, J.A., Ibbotson, R.E., Davis, Z., Wiestner, A., Rosenwald, A., Thomas, P.W., Hamblin, T.J., Staudt, L.M. Oscier, D.G. (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet, 363, 105 111. (Pubitemid 38068326)
36. Oscier, D.G., Gardiner, A.C., Mould, S.J., Glide, S., Davis, Z.A., Ibbotson, R.E., Corcoran, M.M., Chapman, R.M., Thomas, P.W., Copplestone, J.A., Orchard, J.A. Hamblin, T.J. (2002) Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood, 100, 1177 1184. (Pubitemid 34864269)
37. Rassenti, L.Z., Huynh, L., Toy, T.L., Chen, L., Keating, M.J., Gribben, J.G., Neuberg, D.S., Flinn, I.W., Rai, K.R., Byrd, J.C., Kay, N.E., Greaves, A., Weiss, A. Kipps, T.J. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. New England Journal of Medicine, 351, 893 901. (Pubitemid 39096916)
38. Rassenti, L.Z., Jain, S., Keating, M.J., Wierda, W.G., Grever, M.R., Byrd, J.C., Kay, N.E., Brown, J.R., Gribben, J.G., Neuberg, D.S., He, F., Greaves, A.W., Rai, K.R. Kipps, T.J. (2008) Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood, 112, 1923 1930.
39. Schadt, E.E., Li, C., Ellis, B. Wong, W.H. (2001) Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. Journal of Cellular Biochemistry, 84 (Suppl. 37 120 125.
40. Schroers, R., Griesinger, F., Trumper, L., Haase, D., Kulle, B., Klein-Hitpass, L., Sellmann, L., Duhrsen, U. Durig, J. (2005) Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia, 19, 750 758. (Pubitemid 40663094)
41. Shanafelt, T.D., Geyer, S.M., Bone, N.D., Tschumper, R.C., Witzig, T.E., Nowakowski, G.S., Zent, C.S., Call, T.G., Laplant, B., Dewald, G.W., Jelinek, D.F. Kay, N.E. (2008) CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. British Journal of Haematology, 140, 537 546. (Pubitemid 351230080)
42. Shehata, M., Schnabl, S., Demirtas, D., Schwarzmeier, J.D., Hilgarth, M., Duechler, M., Gaiger, A., Hubmann, R. Jaeger, U. (2007) In vitro model for lymphoid microenvironment and inhibition of apoptosis in B-CLL cells: involvment of PI3-K/AKT pathway and PTEN. Haematologica, 92 (Suppl. 1 341.
43. Thunberg, U., Johnson, A., Roos, G., Thorn, I., Tobin, G., Sallstrom, J., Sundstrom, C. Rosenquist, R. (2001) CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood, 97, 1892 1894.
44. Tobin, G., Thunberg, U., Johnson, A., Eriksson, I., Soderberg, O., Karlsson, K., Merup, M., Juliusson, G., Vilpo, J., Enblad, G., Sundstrom, C., Roos, G. Rosenquist, R. (2003) Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood, 101, 4952 4957. (Pubitemid 36857759)
45. Tusher, V.G., Tibshirani, R. Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America, 98, 5116 5121. (Pubitemid 32397092)
46. Wiestner, A., Rosenwald, A., Barry, T.S., Wright, G., Davis, R.E., Henrickson, S.E., Zhao, H., Ibbotson, R.E., Orchard, J.A., Davis, Z., Stetler-Stevenson, M., Raffeld, M., Arthur, D.C., Marti, G.E., Wilson, W.H., Hamblin, T.J., Oscier, D.G. Staudt, L.M. (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood, 101, 4944 4951. (Pubitemid 36857758)